EP3307271
Aðferðir við að nota pýrúvatkínasavirkja
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.6.2016EP published:
13.9.2023EP application number:
16808374.9
EP translation filed:
22.9.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
9.6.2036Expiry date:
9.6.2026Next due date:
30.6.2026
Title in English:
METHODS OF USING PYRUVATE KINASE ACTIVATORSLanguage of the patent:
English
Timeline
Today
10.6.2016EP application
13.9.2023EP Publication
22.9.2023Translation submitted
15.11.2023Registration published
9.6.2026Expires
Owner
Name:
Agios Pharmaceuticals, Inc.Address:
88 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
AGRESTA, Samuel, V.Address:
Lexington, MA 02420, US
Name:
CHEN, YueAddress:
Quincy, MA 02169, US
Name:
COHEN, Marvin, BarryAddress:
Newtown, PA 18940, US
Name:
DANG, Leonard Luan, C.Address:
Boston, MA 02118, US
Name:
KUNG, CharlesAddress:
Arlington, MA 02474, US
Name:
MERICA, Elizabeth, A.Address:
Boston, MA 02130, US
Name:
SILVER, Bruce, AlanAddress:
Dunkirk, MD 20754, US
Name:
YANG, HuaAddress:
Acton, MA 01720, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562174216 PDate:
11.6.2015Country:
US
Classification
Categories:
A61K 31/4709, A61K 31/496, C07D 215/36, A61P 7/06
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 21.5.2024
Expires: 9.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 4.6.2025
Expires: 9.6.2026
Payer: Árnason Faktor ehf.